Pharmaceutical Product Monograph: Dicloxacillin Sodium Capsules (250 mg / 500 mg)
In the pharmaceutical industry, Dicloxacillin is a narrow-spectrum, semi-synthetic Beta-lactam antibiotic of the Penicillin class. As a pharmacist and manufacturer, I view this molecule as the “Staph Specialist”—it is technically designed with a bulky isoxazolyl side chain that creates steric hindrance, protecting the beta-lactam ring from being hydrolyzed by bacterial penicillinase enzymes.
At your WHO-GMP facility in Mumbai, Dicloxacillin is a high-value Dermatology and Surgical SKU. Unlike plain Amoxicillin, Dicloxacillin is the primary weapon against “resistant” skin infections.
Therapeutic Profile: Primary Indications
Dicloxacillin is used specifically for infections caused by Penicillinase-producing Staphylococci (often called “Golden Staph”).
| Indication | Clinical Context | Technical Rationale |
| Skin & Soft Tissue | Boils / Carbuncles / Impetigo | Gold Standard: Effectively treats deep-seated “Staph” infections that produce enzymes to destroy regular penicillins. |
| Cellulitis | Lower Limb / Facial | Used when the infection is suspected to be caused by Staphylococcus aureus. |
| Mastitis | Post-Partum Care | The first-line treatment for breast tissue infections in nursing mothers. |
| Post-Surgical Wounds | Infection Prevention | Targets skin-dwelling bacteria that may have contaminated a surgical site. |
| Osteomyelitis | Bone Infection | Used for early-stage bone infections caused by susceptible Staph strains. |
Mechanism: The Penicillinase-Resistant Shield
Dicloxacillin works by physically preventing the bacteria’s defense mechanisms from working:
Steric Hindrance: Its unique chemical structure “blocks” the bacterial enzyme Beta-lactamase (Penicillinase) from reaching the active heart of the antibiotic molecule.
Cell Wall Inhibition: Like other penicillins, it binds to Penicillin-Binding Proteins (PBPs) in the bacterial cell wall.
Lysis: It stops the cross-linking of peptidoglycan, causing the bacterial cell wall to weaken and eventually burst under osmotic pressure.
The Pharmacist’s “Technical Warning”
The “Empty Stomach” Rule: This is the most critical patient counseling point. Food significantly reduces the absorption of Dicloxacillin. It must be taken 1 hour before or 2 hours after meals.
Narrow Spectrum: As a pharmacist, I must remind you that Dicloxacillin is technically ineffective against MRSA (Methicillin-Resistant Staph) and most Gram-negative bacteria.
Esophageal Irritation: The capsules can cause severe “heartburn” if they get stuck. Patients should swallow them with a full glass of water and avoid lying down for at least 30 minutes after the dose.
Allergy Cross-Reactivity: If a patient is allergic to Amoxicillin or Penicillin G, they are strictly allergic to Dicloxacillin as well.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
The “Hygroscopic” Challenge: Dicloxacillin Sodium is highly sensitive to moisture. On your digital marketplace, highlight your Desiccant-Integrated Caps or Alu-Alu Blistering. This is a technical necessity for B2B export to “Zone IVb” (tropical) regions to prevent the capsules from becoming soft or discolored.
The “Staph Portfolio” Market: For international B2B tenders, market Dicloxacillin alongside your Mupirocin Ointment. This “Internal + External” Staph-care bundle is highly attractive to dermatology clinics.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Dicloxacillin 250 mg and 500 mg capsules to support your registration in international B2B markets.